alexa Abstract | Formulation Design and Evaluation of Fixed Dose Combination of Diclofenac sodium [sustained release] and Rabeprazole sodium [enteric coated].

Asian Journal of Biomedical and Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

The fixed dose combination of diclofenac sodium-sustained release [DIC-SR] and rabeprazole sodium-enteric coated [RAB-EC] was developed. DIC-SR matrix was formulated with xanthan gum using as release retardant to release drug over 24hrs. The concentrations of xanthan gum evaluated at levels of 30%, 40% and 50%. The DIC-SR formulation was optimized by 32 factorial design. RAB-EC was developed with enteric coating polymer Eudragit-S100 at levels of 5%, 10% and 15% weight gain. Instacoat universal®, HPMC based coating material was utilized for primary coating of RAB and secondary coat is given with Eudragit-S100. The optimum batches of DIC-SR and RAB-EC were combined to obtain fixed dose combination and evaluated.

To read the full article Peer-reviewed Article PDF image

Author(s): DD Gadade ND Jagdale RS Kothari AA Heda PK Puranik

Keywords

Diclofenac, Rabeprazole, Sustained release, Enteric coated, Fixed dose combination..

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords